St. Jude Medical Discovers New Cardiac Device Flaws, Issues Patch Update Post author:Sam Post published:February 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Real Estate Developers Eye Boston’s South End for Life Science Campus November 13, 2017 Consolidation Could Be Coming to Pharma Industry March 14, 2018
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017